Gómez Senent Silvia, Gómez Raposo César, Manceñido Marcos Noemi, Martín Chavarri Sonia, Carrión Alonso Gemma, Olveira Martín Antonio, Segura Cabral José María, González Barón Manuel
Department of Gastroenterology, La Paz University Hospital, Madrid, Spain.
Clin Transl Oncol. 2006 Sep;8(9):688-91. doi: 10.1007/s12094-006-0040-x.
Radiofrequency ablation for patients presenting with non-resectable primary or metastatic liver tumours seems to be a valid therapeutic alternative. In the present study, we show a descriptive list of indications, results and complications of Radiofrequency Ablation Technique for treating non-resectable solid hepatic tumours.
Twenty two patients were included in this study; eleven of them (50%) sustained liver metastases from colorectal adenocarcinoma, ten patients (45.5%) had hepatocellular carcinoma and 1 patient had insulinoma.
Local recurrence rate of hepatocellular carcinoma was 22.7% and 27.3% for colorectal carcinoma, after a respective median follow-up of 21 and 14 months. Complications rate was 6.9% and technique-associated mortality rate was 0%.
Radiofrequency ablation is an easy to make, safe and useful technique for the treatment of primary and metastatic liver tumours.
